Ocean Biomedical, Inc. (OCEA) stock
OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026Market cap $45.51KP/E –Yield –
Ocean Biomedical total assets
Total assets on the balance sheet at the end of each period.
Ocean Biomedical's total assets was $1.58M at Mar 31, 2025. For fiscal 2024 it was $902.00K, down 83.6% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $902.00K | -83.6% |
| FY2023 | Dec 31, 2023 | $5.50M | +198.6% |
| FY2022 | Dec 31, 2022 | $1.84M | -98.3% |
| FY2021 | Dec 31, 2021 | $108.65M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | $1.58M | -46.3% |
| Q4 FY2024 | Dec 31, 2024 | $902.00K | -83.6% |
| Q3 FY2024 | Sep 30, 2024 | $1.13M | +9.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.85M | -14.3% |
| Q1 FY2024 | Mar 31, 2024 | $2.95M | +862.7% |
| Q4 FY2023 | Dec 31, 2023 | $5.50M | +198.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.03M | -99.1% |
| Q2 FY2023 | Jun 30, 2023 | $2.16M | -98.0% |
| Q1 FY2023 | Mar 31, 2023 | $306.00K | -99.7% |
| Q4 FY2022 | Dec 31, 2022 | $1.84M | -98.3% |
| Q3 FY2022 | Sep 30, 2022 | $109.13M | +0.2% |
| Q2 FY2022 | Jun 30, 2022 | $108.56M | – |
| Q1 FY2022 | Mar 31, 2022 | $108.34M | – |
| Q4 FY2021 | Dec 31, 2021 | $108.65M | – |
| Q3 FY2021 | Sep 30, 2021 | $108.94M | – |
See a number that looks wrong?